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Regulation of Neuronal Survival and Death by
E2F-Dependent Gene Repression and Derepression
become phosphorylated by cyclin-dependent kinases
(CDKs), which results in expression of a variety of E2F-
responsive genes (Muller et al., 2001). CDK4/6 becomes
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active before CDK2 (Lundberg and Weinberg, 1998) andCenter for Neurobiology and Behavior
appears to phosphorylate Rb in mid-G1. This first stepColumbia University College of
of phosphorylation induces an intramolecular change inPhysicians and Surgeons
Rb, which in turn abolishes its active repression of E2F-New York, New York 10032
responsive genes and uncovers the sites for CDK2 phos-
phorylation (Harbour et al., 1999; Zhang et al., 2000).
The subsequent phosphorylation of Rb at the end of G1Summary
by CDK2-cyclin E complexes promotes the release of
Rb from E2F and consequent E2F-dependent activationNeuronal death induced by a variety of means requires
of S phase genes (Harbour et al., 1999). Therefore,participation of the E2F family of transcription factors.
CDK4/6 and CDK2 complexes are activated and pro-Here, we show that E2F acts as a gene silencer in
mote cell proliferation by phosphorylation of Rb familyneurons and that repression of E2F-responsive genes
proteins in a progressive and sequential manner thatis required for neuronal survival. Moreover, neuronal
includes both gene derepression and transactivation.death evoked by DNA damaging agents or trophic fac-
Cell cycle regulators, especially G1 checkpoint mole-tor withdrawal is characterized by derepression of
cules, have been found to be deregulated in diseasedE2F-responsive genes. Such derepression, rather than
neuronal tissue and apoptotic neurons (Liu and Greene,direct E2F-promoted gene activation, is required for
2001). For example, elevated levels of cyclin D1 mRNAdeath. Among the genes that are derepressed in neu-
or protein are detected in vulnerable neurons followingrons subjected to DNA damage or trophic factor with-
induced ischemia (Guegan et al., 1997) and in neuro-drawal are the transcription factors B- and C-myb.
blastoma cells (Kranenburg et al., 1996) and sympatheticOverexpression of B- and C-myb is sufficient to evoke
neurons under trophic withdrawal (Freeman et al., 1994).neuronal death. These findings support a model in
Furthermore, CDK4 and CDK2 are elevated in neuronswhich E2F-dependent gene repression and derepres-
of patients with Alzheimer’s disease (McShea et al.,sion play pivotal roles in neuronal survival and death,
1997; Zhu et al., 1999), and multiple lines of evidencerespectively.
suggest attempted reentry into cell cycle as a proximal
pathophysiology in AD (Husseman et al., 2000; Raina etIntroduction
al., 2000). However, these observations say little about
how cell cycle proteins work to regulate death.Neuronal apoptosis is an integral part of nervous system
Two neuronal death systems in which the role of spe-development (Oppenheim, 1991) and plays a role in neu-
cific cell cycle molecules has been studied in depth areronal injury and disease (Mattson, 2000). A growing body
that of neurons deprived of trophic support or subjectedof evidence has implicated cell cycle regulators as re-
to DNA damaging agents such as UV irradiation or thequired mediators for neuronal death evoked by treat-
topoisomerase I inhibitor camptothecin. Multiple linesments as diverse as neurotrophic factor deprivation
of evidence support required roles for cyclin D1 and(Park et al., 1997a), DNA damage (Park et al., 1997b,
CDK4/6 activity in these neuronal death paradigms1998), exposure to -amyloid (Giovanni et al., 1999),
(Courtney and Coffey, 1999; Park et al., 1996a, 1997a,
withdrawal of elevated K (Padmanabhan et al., 1999),
1997b, 1998, 2000). For instance, exposure of cortical
and stroke (Osuga et al., 2000). Altered neuronal expres-
neurons to DNA damaging agents elicits a dramatic in-
sion/activity of cell cycle regulators has also been corre- crease of cyclin D-associated kinase activity that is fol-
lated with several neurodegenerative disorders (Zhu et lowed by hyperphosphorylation and subsequent loss of
al., 1999). However, the molecular basis for the involve- Rb family members (Park et al., 1998, 2000). In addition,
ment of cell cycle elements in neuronal apoptosis is expression of D/N CDK4/6 but not D/N CDK2 blocks
unclear. neuronal apoptosis caused by DNA damage or NGF
A number of the cell cycle molecules that have been withdrawal (Park et al., 1997a, 1998). Taken together,
associated with neuronal death converge on regulation these observations support the notion that a cyclin
of the E2F family of transcription factors. Functional E2F D-CDK 4/6-Rb-E2F pathway is a major component of the
transcription factors are heterodimers of E2F and DP apoptotic mechanism in neurons subjected to trophic
proteins, and their activities are also regulated by the Rb factor deprivation or DNA damage.
“pocket” protein family (Chellappan et al., 1991; Dyson, How might CDK 4/6-dependent modification/loss of
1998). During the G1 phase of the cell cycle, pocket E2F-pocket protein complexes lead to neuronal apo-
proteins are in a non- or hypophosphorylated state that ptosis? Death of neurons in many circumstances, in-
inhibits E2F-promoted gene activation and that permits cluding DNA damage and trophic factor withdrawal, re-
E2F sites to act as silencing elements (Harbour and quires gene transcription (Freeman et al., 1994; Morris
Dean, 2000). Upon mitotic stimulation, pocket proteins and Geller, 1996). In this light, the modification/loss of
E2F-pocket protein complexes in DNA-damaged neu-
rons raises two potential mechanisms for changed ex-1 Correspondence: dl345@columbia.edu
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Figure 1. E2F Sites in the B-myb Promoter
Serve as Potent Transcriptional Repressors
in Neuronal Cells and This Repression Is Re-
lieved in Response to Camptothecin and NGF
Withdrawal
(A–C) Activity of luciferase reporter con-
structs driven by the wild-type B-myb pro-
moter and a mutant B-myb promoter in which
the E2F site is compromised by a point muta-
tion. Neuronal PC12 cells, sympathetic neu-
rons, and cortical neurons were transfected
as described in Experimental Procedures, with
Bmyb-luc or Bmyb(Mut)-luc and pcDNA-LacZ.
Later (48 hr), cells were harvested for luciferase
and -gal assays. Results are reported in rela-
tive light units and normalized to -gal activity.
Data are means  SEM (n  3).
(D) Comparison of Bmyb-luc reporter activity
in transfected naive and neuronal PC12 cells.
Transfection and reporter assays were carried
out as in (A). Data are means  SEM (n  3).
(E) Derepression of Bmyb-luc in cortical neu-
rons treated with camptothecin. Transfection
was carried out as above, and, 2 days later,
cells were exposed to camptothecin for the
indicated times and harvested for total RNA.
When used, flavopiridol and actinomycin D
were added to the cultures 30 min before
camptothecin. Expression of luciferase tran-
scripts was quantified by real-time PCR. Re-
sults were normalized to LacZ mRNA. Data
are means  SEM (n  3).
(F) NGF deprivation evokes derepression of Bmyb-luc in neuronal PC12 cells. Transfection of the reporter was carried out as in Experimental
Procedures, and, 2 days later, cultures were washed free of NGF and exposed to anti-hNGF for the indicated time. When used, flavopiridol
was added to the cultures at the time when anti-hNGF was added into the medium. Reporter activity was determined as in (A). Data are
means  SEM (n  3).
pression of apoptotic genes: upregulation of death- vical ganglion (SCG) sympathetic neurons, and embry-
onic cortical neurons. As shown in Figures 1A–1C, theassociated genes by E2F activation and derepression
of proapoptotic genes normally held in check by E2F- reporter with the mutated E2F site exhibited 8-, 18-, and
27-fold greater activity in neuronal PC12 cells, sympa-pocket protein complexes. The purpose of the present
study, therefore, was to determine the roles of E2F- thetic neurons, and cortical neurons, respectively, than
its counterpart with an intact E2F binding site. We ob-dependent gene activation, repression, and derepres-
sion in the survival and death of neurons. Our findings tained similar findings with two additional pairs of lucif-
erase reporters with intact and mutated E2F bindingindicate that neuronal survival requires active gene re-
pression by E2F-pocket protein complexes. Moreover, sites [cdc25A-luc/cdc25A(mut)-luc; Chen and Prywes,
1999; and DHFR-luc/DHRF(mut)-luc; Slansky et al.,we show that derepression but not transactivation of
E2F-responsive genes is required for neuronal death 1993; data not shown].
To ascertain whether repression mediated by E2F ininduced by DNA damage or NGF withdrawal.
neuronal cells reflects their postmitotic state, we also
compared expression of Bmyb-luc in naive and neuronalResults
PC12 cells. The former cells are in an active proliferating
state, whereas the latter leave the cell cycle in responseGene Repression by E2F in Postmitotic Neurons
In replication-competent cells, E2Fs repress their target to NGF treatment (Greene and Tischler, 1976). As shown
in Figure 1D, activity in the naive, proliferating cells wasgenes in G1 and induce their expression in G1/S and S
(Dyson, 1998). Because postmitotic neurons are perma- 7-fold higher than in neuronal cells. This ratio is similar
to that for the mutant versus wild-type reporter in thenently in G0/G1, we first determined whether the E2F
sites in such cells are in a repressive state. To this NGF-treated cultures. Thus, taken together these results
indicate that E2F binding sites mediate potent repres-end, we transfected neuronal cells with an E2F reporter
construct Bmyb-luciferase (Bmyb-luc) or with a control sion of E2F-responsive genes in neurons and neuronal
PC12 cells and that this is associated with their postmi-construct [Bmyb(mut)-luc] containing a mutation that
abolishes E2F binding and measured the luciferase ac- totic state.
tivity. B-myb has been shown to be repressed in G1 and
derepressed in S in an E2F-dependent manner (Lam E2F Repression Is Relieved in Neurons after
Exposure to DNA Damaging Agentsand Watson, 1993). In this and subsequent experiments,
we used three different neuronal culture systems: neu- Exposure of neurons to DNA damaging agents causes
a rapid activation of cyclin D-associated kinase activityronally differentiated PC12 cells, postnatal superior cer-
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Figure 2. Upregulation of B-myb and C-myb
mRNAs in Response to Camptothecin or NGF
Withdrawal
(A) Semiquantitative PCR analysis of B-myb
mRNA. Total RNA was harvested from corti-
cal neurons treated with camptothecin for the
indicated times and converted to cDNA. PCR
reactions were performed 27 and 29 cycles
for B-myb and 20 and 21 cycles for GAPDH.
(B and C) Increase of endogenous B-myb and
C-myb mRNAs in cortical neurons in re-
sponse to camptothecin treatment. Quantita-
tive real-time PCR measurements of B-myb
and C-myb mRNA levels were carried out as
described in Experimental Procedures. Ex-
pression levels were normalized against
GAPDH mRNA. When used, flavopiridol and
actinomycin D were added to the cultures 30
min before camptothecin. Data are means 
SEM (n  3).
(D) NGF withdrawal leads to elevation of en-
dogenous C-myb. Neuronally differentiated
PC12 cells were deprived of NGF for the
indicated times and assessed for levels of
C-myb mRNA as in (B). Data are means 
SEM (n  3).
(E) Flavopiridol and actinomycin D prevent
death of cortical neurons induced by campto-
thecin. Flavopiridol and actinomycin D were
added to cultures 30 min before campto-
thecin. The percentage of surviving neurons
was determined 12 hr later by strip counting.
Experimental points are expressed relative to
the numbers of cells present before treatment
and are reported as means  SEM (n  3).
as well as hyperphosphorylation and loss of pocket pro- protein hyperphosphorylation and degradation (Park et
al., 1997b). These findings thus demonstrate that DNAteins (Park et al., 1998, 2000). This also leads to loss of
E2F-Rb family complexes as judged by gel shift assays damage to neurons evokes a rapid, CDK-dependent
decrease in repression of E2F-responsive genes.(data not shown). We reasoned that the E2F-dependent
gene repression present in healthy neurons may there-
fore be compromised in response to DNA damage. To The E2F-Repressed Genes B-myb and C-myb Are
Upregulated in Neuronstest this possibility, we assessed the relative levels of
luciferase transcripts in neurons transfected with the To investigate the regulation of endogenous E2F-
repressed genes in response to DNA damaging agents,Bmyb-luc reporter and exposed to camptothecin for
various times. The data in Figure 1E indicate that camp- we first carried out semiquantitative RT-PCR on B-myb
mRNA isolated from cortical neurons treated for varioustothecin promotes a rapid increase in luciferase tran-
scripts. Similar findings were achieved with UV treat- times with camptothecin. As shown in Figure 2A, under
the conditions of our PCR assay, we detected a PCRment as well as with cdc25-luc and DHFR-luc reporters
and with neuronal PC12 cell cultures (data not shown). fragment of the expected length only after 6 and 12 hr
of camptothecin treatment, indicating that DNA damageCotreatment with actinomycin D or flavopiridol blocked
the increase. Flavopiridol is a CDK inhibitor that protects leads to elevated B-myb expression. In contrast,
GAPDH-specific primers generated the expected PCRneurons from camptothecin and other DNA damaging
agents and that blocks DNA damage-induced pocket product with equal intensity at all time points of treat-
Neuron
428
Figure 3. Induction of B-myb and C-myb
Proteins in Neuronal PC12 and Cortical Neu-
rons following Exposure to DNA Damaging
Agents
(A and B) Induction of B-myb. Cultures were
treated as indicated and harvested for total
protein. Samples (100 g protein) were sub-
jected to Western immunoblotting with anti
B-myb antiserum. Flavopiridol was added to
culture 30 min before UV or camptothecin
treatment. Membranes were stripped and re-
probed for actin, showing equal loading.
(C and D) Induction of C-myb in cortical neu-
rons. Cultures were treated as indicated,
and 60 g protein per sample was subjected
to Western immunoblotting with anti C-myb
antiserum and, after stripping, anti-actin
antiserum. Flavopiridol, actinomycin D, and
cyclohexamide were added 30 min before
camptothecin where indicated.
(E) Elevation of Myb DNA binding activity in
cortical neurons treated with camptothecin.
A 32P-labeled Myb consensus sequence was
mixed with extracts of camptothecin-treated
cortical neurons for various times as indi-
cated. Electrophoretic mobility shift assays
were performed as described in Experimental
Procedures. For competition experiments,
excess cold probe (20) was added 10 min
before the labeled probe. Reactions were
separated by PAGE on 4% nondenaturing
gels containing TBE.
ment. For quantitative measurements, we employed probe but not by a counterpart with a point mutation in
the Myb binding domain.real-time PCR analysis using GAPDH mRNA levels for
normalization. As shown in Figure 2B, levels of B-myb Taken together, the above findings indicate that the
B- and C-myb genes, whose expression is repressed bytranscripts doubled within 1–2 hr of camptothecin expo-
sure. Parallel experiments revealed a similar response E2F, undergo rapid increases in expression in neurons
subjected to DNA damage. These observations indicateof C-myb mRNA (Figure 2C). These increases were pre-
vented by actinomycin D (Figures 2B and 2C) as well that DNA damage evokes derepression of E2F-regulated
transcripts in neurons.as by flavopiridol (Figure 2C). The data shown in Figure
2E confirm that both actinomycin and flavopiridol also
protected cortical neurons from camptothecin-induced Expression of E2F Mutant Constructs Promotes
Neuronal Apoptosis: Role of Gene Derepressiondeath in these studies.
To examine whether DNA damage also affects the Although the above observations indicate that DNA
damage causes E2F-dependent derepression, they dolevels of the B-myb and C-myb proteins in neuronal
cells, we performed Western blot analyses of whole-cell not exclude an accompanying elevation in E2F-depen-
dent gene transactivation and therefore do not distin-extracts of UV- and camptothecin-treated PC12 cells
and cortical neurons. As shown in Figures 3A and 3B, guish between the potential roles of these two re-
sponses in neuronal death. To achieve this distinction,levels of B-myb protein increased within 2 hr of treat-
ment and remained elevated for at least 12 hr. Similar we transfected a variety of E2F1 constructs (Figure 4A)
into neuronal cells and monitored their effects on Bmyb-results were found for levels of C-myb protein in UV-
(data not shown) or camptothecin-treated (Figures 3C luc activity and survival.
E2F1(1-368) is a truncated form of E2F1 that lacksand 3D) cortical neurons. The increases in Myb proteins
were suppressed by flavopiridol (Figures 3A–3C), actino- both the activation and Rb binding domains (Figure 4A;
Sellers et al., 1995). This therefore acts as a dominantmycin D (Figure 3D), or cyclohexamide (Figure 3D), indi-
cating the elevated protein levels were dependent on negative that suppresses E2F1-dependent transactiva-
tion and, by virtue of its inability to bind pocket proteins,both ongoing transcription and translation as well as on
CDK activity. displaces endogenous E2F complexes, causing dere-
pression of certain E2F-responsive genes in neuronsWe next determined whether the elevated levels of
Myb proteins in camptothecin-treated neurons have the (Zhang et al., 1999). Figure 4B shows that cotransfection
of E2F1(1-368) along with Bmyb-luc resulted in in-capacity to bind DNA. Figure 3E shows a gel shift carried
out using a radiolabeled Myb-specific DNA probe and creased expression of the latter by about 4-fold. Similar
findings were achieved with cortical and sympatheticextracts of camptothecin-treated cortical neurons. Myb
binding was barely detectable before treatment and was neurons (data not shown) as well as with another con-
struct, E2F1(FS409) (Johnson et al., 1993), that containsreadily observable within 30 min and persisted to at least
8 hr. Binding was eliminated by excess (20) unlabeled a frameshift mutation that abolishes the Rb interaction
E2F Regulation in Neuronal Survival and Death
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Figure 4. Effect of Different E2F Constructs and E2F Decoys on B-myb Promoter Expression in Neuronal PC12 Cells and in Sympathetic
Neurons
(A) Summary of the properties of E2F constructs and E2F decoys used in this study. See text for details.
(B) Upregulation of B-myb promoter expression by E2F activation and E2F derepression in neuronal PC12 cells. The indicated E2F constructs
were cotransfected with Bmyb-luc and pcDNA-LacZ. Later (24 hr), cells were harvested and used for luciferase and -gal assays. Luciferase
activity was normalized against -gal activity. Data represent means  SEM (n  3).
(C) An E2F decoy causes derepression of B-myb promoter activity in SCG neurons. SCG neurons were cotransfected with E2F decoys and
Bmyb-luc and pcDNA-LacZ as in Experimental Procedures. Relative luciferase activities were obtained as described in (B). Data represent
means  SEM (n  3).
domain and compromises transactivation activity (data and derepression. It is of interest that the degree of
regulation of Bmyb-luc reporter activity by E2F1(1-368)not shown). In contrast, cotransfection with wild-type
E2F1 elevated luciferase activity by more than 50-fold is similar in magnitude to that which occurs in response
to DNA damage.(Figure 4B). This difference most likely reflects the ca-
pacity of wild-type E2F1 to promote both transactivation We next tested the effect of E2F1 and E2F1(1-368) on
Neuron
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Figure 5. Derepression of E2F-Regulated Genes in Neurons Causes Apoptosis whereas Rb-Promoted Repression of E2F-Regulated Genes
Does Not
(A and B) Neuronal PC12 cells. Indicated E2F, Rb, and E2F decoy constructs were cotransfected with pEGFP into neuronal PC12 cells as in
Figure 1, and effects were assessed 2 days later. (A) Survival was assessed by strip counting numbers of GFP-positive cells. Results are
expressed relative to survival with the control vector alone. (B) Death was assessed by determining the percentage of GFP-positive apoptotic
nuclei over the total number of GFP-positive cells scored. Data are presented as means  SEM (n  3).
(C–E) Sympathetic neurons. Sympathetic neurons were cotransfected with the indicated E2F decoys (C) and E2F and E2F-Rb fusion constructs
(D and E) along with pEGFP. The percentages of surviving neurons (C and D) and of apoptotic nuclei (E) were determined as in (A) and (B).
survival of neuronal PC12 cells (Figures 5A and 5B), dogenous E2F-repressive complexes, the death re-
sponse to their expression should not be attributable tosympathetic neurons (Figures 5D and 5E), and cortical
neurons (data not shown). In each culture type, in con- E2F-mediated gene activation but rather to E2F dere-
pression. To further test this hypothesis, we employedtrast to their huge disparity in upregulating B-myb pro-
moter activity, both constructs were similarly effective an additional E2F1 mutant, E2F1(E132), which has muta-
tions that abolish its E2F site binding activity (Johnsonin promoting massive death. Similar findings were
achieved with E2F1(FS409) (data not shown). et al., 1993). This mutant should not directly displace
endogenous E2F1 complexes from DNA but shouldThe above findings are consistent with the interpreta-
tion that both wild-type and E2F1 mutants induce death rather compete for pocket proteins, thereby alleviating
the repressive effect of endogenous E2F-pocket proteinby displacing endogenous repressive E2F-pocket pro-
tein complexes, thereby relieving repression of genes complexes. As shown in Figure 4B, E2F1(E132) en-
hances the expression of Bmyb-luc to a degree similar toincluding those that promote death. Since the E2F mu-
tant constructs lack transactivation activity but possess that achieved with E2F1(1-368). Moreover, this construct
was also comparably effective in inducing death of neu-DNA binding activity that permits displacement of en-
E2F Regulation in Neuronal Survival and Death
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Figure 6. Photographs of Effect of E2F Decoys, Rb(379-792), and E2F-Rb Fusions on Survival of SCG and Cortical Neurons
(A) Expression of an E2F decoy induces apoptosis of SCG neurons. Transfection of the indicated constructs and pEGFP was carried out as
in Figure 5. At 2 days after transfection, cells were fixed and stained with Hoechst 33342. Neurons were observed under green fluorescence,
UV, and phase. Arrows (panels AD, AG, and AJ) show gold particles associated with Gene Gun transfection. Scale bars represent 100 m in
(AA) and 20 m in (AB)–(AJ), respectively.
(B) Effect of E2F repression and derepression on survival of cortical neurons. Cortical neurons were cotransfected with pEGFP and the
indicated constructs. At 2 days after transfection, half of the transfected cells were exposed to camptothecin (panels BB, BD, BF, and BH).
Photos were taken 48 hr later under UV illustration to show GFP-positive cells. Scale bar represents 50 m.
ronal PC12 cells (Figures 5A and 5B) as well as of sympa- neuronal PC12 cells (Figure 5B) effectively evoked
death; in contrast, the construct containing mutated E2Fthetic and cortical neurons (data not shown).
sites (E2F-Mut24) had relatively little effect on survival.
These observations further support the notion that dere-An E2F Binding Site Decoy Causes Transcriptional
Derepression and Induces Neuronal Death pression of E2F-repressed genes can evoke neuronal
death and that death does not require E2F-dependentAs an alternative strategy to E2F1 mutants, we also
employed transfection with an E2F binding site “decoy” gene transactivation.
(E2F-Comp24) consisting of 24 repetitive DNA binding
sites for E2F (Figure 4A; He et al., 2000). This construct Repression of E2F-Responsive Genes Rescues
Neurons from Apoptosis Inducedcompetes with cellular DNA for endogenous E2F binding
activities, thereby suppressing transactivation and also by DNA Damage
Because E2F derepression occurs in response to neu-promoting gene derepression (He et al., 2000). Cotrans-
fection of the decoy into sympathetic neurons (Figure ronal DNA damage and in light of our observations that
forced E2F derepression evokes neuronal death, we4C) or neuronal PC12 cells (data not shown) along with
Bmyb-luc results in a 5-fold elevation of luciferase activ- next wished to determine whether blockade of E2F dere-
pression would suppress death of neurons. One strategyity compared with that in cells cotransfected with empty
vector. In contrast, a similar construct of E2F binding to this end was to force expression of wild-type Rb or
of phosphorylation-resistant Rb small pocket [Rb(379-sites containing a point mutation that suppresses bind-
ing of E2F (E2F-Mut24) showed significantly less effect 795); Chow and Dean, 1996]. A different phosphoryla-
tion-resistant Rb mutant was previously found to par-on luciferase activity. Transfection of the decoy con-
struct into sympathetic neurons (Figures 5C and 6) or tially protect cortical neurons from death evoked by
Neuron
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Figure 7. Rb- and E2F-Rb-Mediated Gene Repression Protects Neuronal PC12 Cells from Apoptosis Induced by DNA Damaging Agents and
Sympathetic Neurons from NGF Withdrawal
(A) Neuronal PC12 cells were cotransfected with indicated constructs and GFP and 2 days later were exposed to UV irradiation (650 J/m2).
GFP-positive cells were quantified on the following 2 days by strip counting. Data are expressed as relative to day 0 (before irradiation) and
are given as means  SEM (n  3).
(B) Neuronal PC12 cells were transfected with the indicated constructs and 2 days later were treated with camptothecin. The percentages of
apoptotic nuclei were assessed before and 24 hr after camptothecin treatment as described in Experimental Procedures. Data are expressed
as relative to untreated controls and are given as means  SEM (n  3).
(C) Sympathetic neurons were cotransfected with the indicated constructs and GFP and 2 days later were deprived of NGF. Numbers of GFP-
positive cells were evaluated at each indicated time, and data are expressed relative to day 0 (before NGF withdrawal) and are given as
means  SEM (n  3).
DNA damage (Park et al., 2000). These constructs had impaired repressor displaces endogenous E2F-pocket
protein complexes, thereby inducing derepression. Sim-minimal effect on survival of neuronal PC12 cells in the
absence of DNA damage (Figures 5A and 5B) and signifi- ilar observations were made with sympathetic and corti-
cal neurons (data not shown). When the two constructscantly depressed death evoked by UV (Figure 7A) or
camptothecin (Figure 7B) treatment. Similar results were were tested for effects on survival of sympathetic neu-
rons, E2F1(1-368)-Rb(379-792) had little if any effect,achieved with sympathetic (data not shown) and cortical
(Figure 6 and data not shown) neurons. The better pro- whereas E2F1(1-368)-Rb(379-928)ex22 induced a sig-
nificant level of death (Figures 5E and 6B). These obser-tection conferred by Rb(379-795) as compared to wild-
type Rb at 2 days following UV irradiation is consistent vations are consistent with and support our observa-
tions that derepression of E2F-responsive genes iswith the notion that phosphorylation of Rb is an impor-
tant step in its inactivation and eventual removal during sufficient to induce apoptosis and that active repression
of E2F-responsive genes rather than blockade of E2Fthe apoptotic process.
Although the above strategy reinforces the impor- activation is required for neuron survival.
We next evaluated the role of E2F-mediated genetance of non- or hypophosphorylated pocket proteins
in neuronal survival, they do not distinguish between derepression in death evoked by DNA damage. Neu-
ronal cultures were transfected with the two E2F-Rbpotential actions of Rb in blocking E2F-dependent trans-
activation or in facilitating E2F-dependent active gene fusion constructs, subjected to DNA damage, and
then assessed for survival. As shown in Figure 7,repression. We therefore tested a construct encoding a
fusion protein [E2F1(1-368)-Rb(379-792) that includes E2F1(1-368)-Rb(379-792) but not E2F1(1-368)-Rb(379-
928)ex22 provided strong protection from UV irradia-the DNA binding and dimerization domains of E2F1 and
the pocket domain of Rb; Figure 4A; Sellers et al., 1995]. tion (Figure 7A and data not shown for sympathetic and
cortical neurons) and camptothecin (Figures 6B and 7B).This fusion protein not only should be unable to activate
E2F-responsive genes, but should repress them by These findings further support the conclusion that dere-
pression of E2F-responsive genes is required for neu-means of the Rb moiety. As a control, we used the
construct E2F1(1-368)-Rb(379-928)ex22, which has an ronal apoptosis and that repression of such genes is
protective against neuronal apoptosis induced by DNAexon 22 deletion and impaired function for repression
(Sellers et al., 1995; Figure 4A). When tested for de- damage.
repression activity by cotransfection with Bmyb-luc,
E2F1(1-368)-Rb(379-792) exerted little effect (Figure 4B), Forced Expression of B-myb and C-myb Induces
Neuronal Deathindicating that E2F in neuronal cells is repressed to such
a level that expression of another E2F repressor does If derepression of E2F-responsive genes plays a role in
the neuronal apoptotic response, then forced expres-not further affect reporter activity. In contrast, E2F1(1-
368)-Rb(379-928)ex22 coexpression increased re- sion of at least some of these might be anticipated to
induce death. To test this, we transfected neuronal PC12porter activity by 2.5-fold (Figure 4B), indicating that this
E2F Regulation in Neuronal Survival and Death
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elevated by 6-fold within 10 hr (Figure 1F), indicating
that NGF withdrawal relieves repression of the B-myb
promoter by E2F. In support of the latter, this upregula-
tion was blocked by the presence of flavopiridol (Figure
1F). Examination of the endogenous levels of C-myb
transcripts confirmed that these undergo a similar eleva-
tion following NGF withdrawal and revealed that flavopi-
ridol eliminated this response (Figure 2D). We also ob-
served an increase in levels of endogenous B-myb
protein within 2 hr of NGF withdrawal (data not shown).
Thus, derepression of the Myb promoters is induced by
NGF withdrawal as well as by DNA damaging agents.
We next tested whether blockade of E2F derepression
by the E2F-Rb fusion protein would protect neurons
from apoptosis induced by NGF withdrawal (Figure 7C).
We cotransfected sympathetic neurons with GFP and
different Rb constructs, and, 2 days later, NGF was
removed and the medium replaced with one containing
anti-NGF antibody. Counts of GFP-positive neurons re-
vealed that E2F1(1-368)-Rb(379-792) promoted survival
rates of 95% and 88% after 1 and 2 days of NGF with-
drawal, respectively. In contrast, the corresponding mu-
tant version of the fusion protein, E2F1(1-368)-Rb(379-
Figure 8. Overexpression of B-myb and C-myb Induces Apoptosis 928)ex22, showed no protection compared with the
of Neuronal PC12 Cells and Cortical Neurons vector control (ca. 60% and 35% survival after 1 and
(A and B) B-myb and C-myb cause apoptosis of neuronal PC12 cells. 2 days, respectively). These results indicate that E2F
B-myb and C-myb were cotransfected with pEGFP, and survival was derepression is an underlying mechanism of apoptosis
assessed both as percentage of surviving GFP-positive cells (A) and
evoked by NGF withdrawal as well as by DNA damage.as percentage of apoptotic nuclei (B). Data are given as means 
SEM (n  3).
(C and D) B-myb and C-myb cause apoptosis in cortical neurons Discussion
even when derepression of E2F-responsive genes is blocked. Neu-
rons were cotransfected with pEGFP and the indicated constructs. Role of E2F-Dependent Gene Repression and
Survival was accessed as in (A) and (B). Data are given as means  Derepression in Neuronal Survival and Death
SEM (n  3).
Prior studies have implicated the cyclin D-CDK4/6-
pocket protein-E2F pathway in a variety of neuronal
death paradigms and have suggested that E2F is a keycells and cortical neurons with B-myb and C-myb and
regulator of at least some of the transcriptional events
48 hr later monitored both numbers of surviving cells
that are required for neuronal apoptosis (Park et al.,
and cells with apoptotic nuclei. As shown in Figures 8A
1996a, 1997a, 1997b, 1998, 2000; Liu and Greene, 2001).
and 8B, both constructs evoked death. According to Because E2F may function either as a transcriptional
our model, these genes should act downstream of E2F activator or transcriptional corepressor, we asked which
derepression and thus should induce death even when of these two mechanisms might be important for neu-
E2F-mediated repression is enforced. The data in Fig- ronal survival and for neuronal death.
ures 8C and 8D indicate that, in contrast to its capacity Our findings revealed strong repression of E2F re-
to inhibit DNA damage-induced death, E2F-specific porter constructs when these were expressed in neu-
transrepressor E2F1(1-368)-Rb(379-792) does not in- ronal PC12 cells and neurons. This indicates that E2F
hibit death evoked by either B-myb or C-myb. functions primarily as a transcriptional repressor in such
cells. Presumably, the absence of E2F transactivational
E2F-Mediated Derepression Is Involved activity and the presence of E2F-dependent repression
in Neuronal Death Induced play an important role in maintaining neurons and NGF-
by NGF Withdrawal treated PC12 cells in a postmitotic state. This notion is
As in the case of DNA damage, death of sympathetic supported by our observation that the activity of an E2F
neurons and neuronal PC12 cells evoked by NGF with- reporter was substantially higher when expressed in
drawal is suppressed by flavopiridol, a CDK4/6 inhibitor proliferating PC12 cells.
(Park et al., 1996a). Likewise, CKIs and dominant-nega- A second major observation was that forced derepres-
tive CDK4 and 6 (but not CDK2) also protect such cells sion of E2F-responsive genes caused neuronal cell
from NGF deprivation (Park et al., 1997b), and, in this death, even in the presence of a trophic factor such as
model, elevation of C-myb mRNA has been reported NGF. This was achieved by two different approaches,
(Estus et al., 1994). To test whether E2F-mediated dere- namely, overexpression of E2F dominant-negative pro-
pression is also a component of death in this paradigm, teins lacking activation domains or with mutant DNA
we transfected the Bmyb-luc reporter into neuronal binding domains and by transfection with an E2F DNA
PC12 cells and followed luciferase activity during the decoy with multiple E2F binding sites. Such findings
course of NGF withdrawal. Reporter activity was more indicate that E2F-mediated gene repression not only
occurs in neurons, but is required for their survival.than doubled within 2 hr of NGF withdrawal and was
Neuron
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A third finding was that DNA damaging agents or NGF 2000). Although the favored interpretation was that E2F
stimulated transactivation of death genes, an equallywithdrawal led to derepression of E2F-inhibited genes.
This was indicated by elevated expression of E2F re- and perhaps more plausible interpretation would be that
excess exogenous E2F displaced endogenous repres-porter constructs as well as by transcription-dependent
elevation of endogenous B- and C-myb mRNAs and sive E2F-pocket protein complexes at E2F sites, thereby
causing derepression of apoptotic genes. This interpre-proteins. E2F acts as a corepressor for these genes
in healthy neurons, and, hence, the increase in their tation is supported by our observations that E2F mutants
without a transactivation domain and an E2F decoy con-expression following DNA damage or NGF withdrawal
supports the occurrence of derepression during the struct also promote neuronal death. Finally, overexpres-
sion of phosphorylation-resistant Rb mutants partiallydeath process.
A fourth observation was that death promoted by DNA protected neurons from death evoked by DNA damage
(Park et al., 2000; present study) or NGF deprivationdamage or NGF withdrawal was blocked when dere-
pression of E2F-responsive genes was abolished. This (present study). Here again, our interpretation is that
the Rb mutants replaced phosphorylated endogenouswas achieved by transfection with a construct encoding
an E2F-Rb fusion protein that should act as a transcrip- pocket proteins in complexes with E2F, thereby re-
taining gene repression. This interpretation is stronglytional repressor, even under conditions in which cyclin
D-CDK4/6 activity is elevated. supported by our observations that E2F-tethered Rb
effectively protected neurons from death evoked by ei-
ther DNA damage or NGF withdrawal.Regulation of E2F-Mediated Derepression
Although our data are consistent with the requiredRecent studies suggest a sequential role for E2F-depen-
involvement of E2F-mediated gene derepression in neu-dent derepression and activation in cell cycle progres-
ronal death, they do not support an obligatory role forsion (Harbour and Dean, 2000; Harbour et al., 1999).
E2F-dependent gene transactivation in this process. IfIn nonproliferating cells, association of pocket proteins
the latter possibility were the case, then dominant-nega-with E2F inhibits its transactivational activity and ac-
tive E2F constructs and the E2F binding decoy shouldtively promotes gene repression (Zhang et al., 1999).
have promoted survival rather than death. Of additionalThis has the net effect of silencing genes associated
potential relevance, past studies in several nonneuronalwith DNA synthesis and mitosis and contributes to the
cell lines have shown that, while E2F activation pro-quiescent state. During the transition through G1 toward
motes cell proliferation, it is not required to promoteS, cyclin D-CDK4/6 activity becomes elevated, leading
apoptosis (Hsieh et al., 1997; Phillips et al., 1997).to an initial phosphorylation of pocket proteins. The ef-
fect of this phosphorylation is to relieve repression by
E2F-pocket protein complexes, presumably by affecting A Pathway to Neuronal Death Evoked by DNA
Damage or NGF Withdrawalassociation with HDAC and CtBP (Harbour and Dean,
2000; Meloni et al., 1999). This derepression evokes in- Taken together, our findings suggest a pathway by
which DNA damage or NGF withdrawal leads to E2F-duction of a subset of genes that may include many
associated with cell cycle progression, such as B- and dependent gene derepression and to neuronal death
(Figure 9). The first well-defined step in this pathway isC-myb, cdc6, and cyclin E. The elevation of cyclin E is
postulated to activate CDK2 and permits E2F transacti- elevation of cyclin D-associated kinase activity. Past
evidence indicates that such an increase is driven byvational activity by further phosphorylation of pocket
proteins. This in turn induces additional genes required a combination of events, including elevation of cyclin
D-associated kinase activity (Park et al., 1998) as wellfor subsequent steps in cell cycle progression (Harbour
and Dean, 2000). as by translocation of cyclin D to the nucleus (Padmana-
bhan et al., 1999). The enhancement of cyclin D-associ-Both the present and past observations are consistent
with the interpretation that apoptotic stimuli, including ated kinase activity promotes hyperphosphorylation of
pocket proteins bound to E2F, which compromises theirDNA damage and NGF deprivation, lead to events that
favor E2F-promoted gene derepression and that this, capacity to mediate gene repression. The consequent
deregulation of genes elevates cellular levels of proapo-rather than E2F-dependent gene activation, plays a re-
quired role in neuronal apoptosis. For instance, neuronal ptotic proteins that contribute to neuronal death.
Although the E2F derepression pathway describeddeath is blocked by G1/S inhibitors but not by those
acting at later stages in the cell cycle (Farinelli and here may be required and sufficient for neuronal death,
this does not exclude involvement of other pathways inGreene, 1996). This suggests a particular vulnerability
at the G1/S checkpoint, which is at the place in the cycle this regard. For instance, activation of the JNK/c-Jun
pathway also appears to be required for neuronal deathat which E2F-mediated derepression appears to occur
(Harbour et al., 1999). In addition, dominant-negative evoked by DNA damage and NGF deprivation as well
as additional causes (Maroney et al., 1999). However,CDK4 and CDK6 protect neurons from apoptosis evoked
by DNA damaging agents and NGF withdrawal, whereas activation of the two pathways appears to be indepen-
dent (Park et al., 1996b). In addition, p53 also appearsdominant-negative CDK2 does not (Park et al., 1997a,
1998). In light of the postulated specific roles for CDK4/6 to play a required role in neuronal death elicited by DNA
damage (cf. Morris et al., 2001) and NGF deprivationand CDK2 discussed above, these observations again
favor gene derepression rather than activation as a re- (Aloyz et al., 1998). In this respect, it had been shown
in proliferation-competent cells that E2F1 may inducequired player in the death process. Several studies have
reported that overexpression of E2F promotes death of p53-dependent (Qin et al., 1994) as well as p53-indepen-
dent apoptosis (Macleod et al., 1996). Very recent evi-postmitotic neurons (Athanasiou et al., 1998; Hou et al.,
E2F Regulation in Neuronal Survival and Death
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Figure 9. A Model for E2F Repression/Derepression in Neuronal Survival and Apoptosis
dence (Morris et al., 2001), however, indicates that the Our experiments revealed rapid induction of the B-
and C-myb proteins in cortical neurons, sympatheticE2F and p53 pathways in neurons are independently
regulated in response to DNA damage; in the case of neurons, and neuronal PC12 cells in response to DNA
damage or NGF withdrawal and that forced expressionNGF deprivation, E2F activation has been suggested to
be downstream of the JNK/c-Jun pathway (Aloyz et al., of these proteins causes neuronal apoptosis. Transfec-
tion with Myb family members has been shown to pro-1998). In proliferation-competent cells, overexpression
of E2F can also cause apoptosis by direct induction of mote cell cycle progression and to cause death of non-
neuronal cell types as well (Athanasiou et al., 1996; Biesthe p53 family member p73 (Stiewe and Putzer, 2000).
However, at least for NGF deprivation, death appears and Wolff, 1995; Sala et al., 1996). Such observations
support the possibility that elevation of Myb proteinto be associated with disappearance of the p73 deriva-
tive p63 rather than to upregulation of p73 itself (Pozniak levels in postmitotic neurons contributes to death
evoked by DNA damage or NGF withdrawal. Our findinget al., 2000). Thus, as previously suggested (Park et
al., 1996b), neuronal death appears to result from the that Myb proteins promoted death even when cotrans-
fected with an E2F-Rb fusion construct indicates thatactivation and convergence of several independent
transcriptional pathways. these act even when E2F-dependent derepression is
blocked and therefore can be sufficient to induce death
in the absence of other derepressed genes. The mecha-Myb Proteins and Neuronal Death
nism by which Mybs induce neuronal death is unclear,Although genes that are subject to E2F-mediated dere-
but, given that these proteins are transcription factors,pression seem to play a prominent role in neuronal apo-
it seems likely that they in turn regulate proapoptoticptosis in response to DNA damage and NGF withdrawal,
genes.the identities of these proapoptotic genes have yet to
be fully defined. However, among the candidates are B-
and C-myb. A relatively low, basal level of these proteins E2F-Mediated Derepression in Other Paradigms
of Neuronal Deathwas detected in control neuronal cultures. It is unclear
whether this reflects a basal level of death or that Myb The data presented here pertained specifically to neu-
ronal death promoted by DNA damaging agents andproteins play physiological functions in healthy neurons.
Of relevance to this, in situ hybridization is reported to NGF deprivation. However, similar mechanisms may apply
to neuronal death evoked by a variety of additional apo-reveal low levels of C-myb mRNA in many different neu-
ron types in adult brain (Shin et al., 2001). ptotic stimuli. Death evoked by application of -amyloid
Neuron
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total number of GFP-positive cells assessed. All experiments wereprotein (Giovanni et al., 1999) and oxygen deprivation
performed in triplicate and are reported as mean  SEM (n  3).(Osuga et al., 2000) as well as by DNA damage (Park et
al., 1996b) and NGF deprivation (Park et al., 1996a) is
Luciferase Assaysuppressed by flavopiridol, a CDK4/6 inhibitor. Further-
Neurons or PC12 cells were transfected as described above, with
more, hyperphosphorylation and cleavage of pocket appropriate luciferase reporter and pcDNA-LacZ with or without
proteins is associated with repolarization-induced death other DNAs. At 24 or 48 hr later, cells were washed with cold PBS,
triturated off the plates, and pelleted in microcentrifuge tubes. Cellof cerebellar granule cells (Padmanabhan et al., 1999).
pellets were lysed in buffer provided in the Promega LuciferaseThus, E2F-mediated derepression may well be a compo-
System (Promega). Luciferase assay was carried out according tonent of death in a variety of neuronal death paradigms.
the manufacturer’s instructions, using a TD-20/20 Luminometer
(Turner Designs). Relative luciferase activities were obtained by nor-
Experimental Procedures malizing the luciferase activity against -gal activity. Data are pre-
sented in the text and figures as mean  SEM (n  3).
Culture and Transfection of PC12 Cells, Cortical Neurons,
and Sympathetic Neurons Semiquantitative RT-PCR and Quantitative PCR
PC12 cells, embryonic rat cortical neurons, and neonatal rat superior RNA was isolated from cells using TriReagent (Molecular Research
cervical ganglion sympathetic neurons were cultured as previously Center) as described by the manufacturer. Reverse transcription
described (Greene and Tischler, 1976; Park et al., 1998). was carried out using Superscript II reverse transcriptase (Life Tech-
Transfection protocols were as follows. nologies) following the manufacturer’s instructions. Semiquantita-
PC12 Cells tive PCR (GeneAmp PCR System 9700, Perkin-Elmer) was carried
Naive or neuronal PC12 cells in 24-well dishes were transfected out using Platinum Taq DNA polymerase (Life Technologies) follow-
using LipofectAMINE plus or LipofectAMINE 2000 (Life Technolo- ing the manufacturer’s instructions. For B-myb, oligonucleotides
gies) following the manufacturer’s standard protocol. All cDNA con- GGGCTCAGGCATTGGCACACC and GTGTGGGGAGTGTTGTCC
structs were used at 1 g/well; E2F decoys were at 0.5 g/well. ATGG were used (27 to 29 cycles). For GAPDH, oligonucleotides
Cortical Neurons ACCACAGTCCATGCCATCAC and TCCACCACCCTGTTGCTGTA
Transfection of cortical neurons was carried out 3 days after plating were used (20 to 21 cycles).
as described for PC12 cells, except that the transfection medium Quantitative PCR was carried out using a Cepheid SmartCycler
was replaced with fresh medium after 5–6 hr. following the manufacturer’s specifications. cDNA was added to a
Sympathetic Neurons 25 l volume reaction mix containing Ready-to-go Beads (Amer-
On the third day after plating, neurons were transfected with a Helios sham Manheim Pharmaceuticals) and SYBR Green I (Molecular
Gene Gun System (BioRad). In brief, DNA was loaded on microcar- Probes) together with appropriate primers at 0.2 M each. Analyses
riers (1.6 m) with a ratio of DNA:gold carrier (2 g:1 mg) according of growth curves of real-time fluorescence and of melting curves
to manufacturer’s protocol (BioRad). Medium was carefully removed were carried out as described before (Troy et al., 2001). GAPDH
from the wells shortly before shooting and replaced immediately was used to normalize input cDNA. Levels of luciferase mRNA in
after. The Gene Gun was held perpendicularly over the culture dish reporter transfection assays were also normalized by -gal mRNA
and about 1.5 cm above the surface of the cell layer. Pressure was levels. The same oligonucleotides listed above were used for B-myb
set at 200 psi. Even distribution of gold particles was monitored by and GAPDH: CGGTCCCCTGAAGATGCTACCT and GGTCCTCTG
microscopic observations. TCTTCCCACAGGA for C-myb; CGCTGCTGGTGCCAACCCT and
GGCGTTGGTCGCTTCCGGA for luciferase; CCGACCCAGCGCCCG
TTGCA and GGCCCGCACCGATCGCCCTT for -gal.UV Irradiation, Camptothecin Treatment,
and NGF Withdrawal
Neurons or PC12 cells were exposed to UV irradiation at 350 J/m2 Western Blot Analyses
(cortical and sympathetic neurons) or 650 J/m2 (PC12 cells), respec- Cell extracts from cortical neurons or neuronal PC12 cells were
tively, in a Stratolinker UV crosslinker (Stratagene) (Park et al., 1998). prepared as described (Padmanabhan et al., 1999). Protein concen-
For camptothecin (Sigma) treatment, stock (10 mM in DMSO) was tration was determined by Bradford assay (BioRad). Western immu-
diluted and dissolved in medium and then added to cultures to a noblotting was carried out as described (Park et al., 1998). Anti
final concentration of 10 M. Flavopiridol (L86-8275, [(-)-cis-5,7- B-myb antibody (Santa Cruz) and anti C-myb antibodies (Santa Cruz
dihydroxy-2-(2-chlorophenyl)-8[4-(3-hydroxy-1-methyl)-piperidinyl]- and Upstate Laboratories) were used at 1:200, 1:200, and 1:1000,
4H-benzopyran4-1], a generous gift from Dr. Peter J. Worland, Na- respectively. Prior to reprobing with anti-actin (1:500), membranes
tional Cancer Institute), actinomycin D, and cyclohexamide (both were exposed overnight at room temperature to stripping buffer
from Sigma) were added 30 min before UV or camptothecin treat- (62.5 mM Tris [pH 6.8], 100 mM BME, 2% SDS) and washed exten-
ment as indicated. sively with PBS.
For NGF withdrawal, sympathetic neurons or PC12 cell cultures
were washed twice with NGF-free RPMI 1640 medium and treated Gel Shift Assay
with anti-hNGF antiserum (Sigma, 1:200 dilution). Electrophoretic mobility shift assays (EMSAs) were performed es-
sentially as described by Chellappan et al. (1991). Where appro-
priate, a 20-fold excess of unlabeled probe (wild-type or with a pointSurvival Assay
mutation; Santa Cruz) was added to the reactions 10 min beforeStrip Counting
the 32P-labeled Myb probe (Santa Cruz) was added.In brief, a 24-well plate was placed onto a moveable microscope
stage. The numbers of GFP-positive cells in a defined strip across
the culture were assessed by phase and fluorescence microscopy. Acknowledgments
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